normative
Pay-for-performance reimbursement for durable medicines
Long-durability medicines whose benefits accrue years later face a reimbursement problem because Americans change insurers every 3-4 years, so no insurer is incentivized to cover a benefit realized in the out-years; a pay-for-performance model—paying a fraction of the cost each year contingent on demonstrated ongoing benefit—aligns incentives, treating the therapeutic's cost-lowering effect like a pre-existing condition that follows the patient between payers.
normativepending
Speaker
Jacob KimmelEvidence Quote
“rather than reimbursing all of the cost of the drug upfront, you reimburse it over time.”
Created: 6/13/2026, 3:28:32 AM
Your notes
Loading notes...